-
effectivehealthcare.ahrq.gov/sites/default/files/covariate-selection-chapter-7.pptx
January 01, 2013 - For example, family history of heart disease is a measured variable indicating someone’s risk for cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
October 01, 2010 - In-Hospital, Off-Label
Uses for rFVIIa1 Evidence on Benefits vs. Usual Care Evidence on Harms vs. Usual Care
Spontaneous
intracranial
hemorrhage*
No effect on mortality or functional status. ���
Attenuation of hematoma expansion. ���
Increased risk for arterial thromboembolic
events, particularly at doses >40 …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
February 01, 2011 - with no KD codes); (2) beneficia-
ries with intermittent KD (beneficiaries
with occasional diagnoses indicating
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
February 01, 2009 - DMARD utilization
increased over time indicating that more RA patients who used DMARDs, remained on
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-213-lower-limb-protheses-evidence-summary.pdf
September 01, 2018 - Evidence Summary-Comparative-Effectiveness-Review-213-Lower-Limb-Prostheses
Comparative Effectiveness Review
Number 213
Lower Limb Prostheses: Measurement Instruments,
Comparison of Component Effects by Subgroups, and
Long-Term Outcomes
Evidence Summary
Introduction
Background
An estimated 1.9 million people…
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - health care delivery infrastructure and
patient management with oral or transdermal scopolamine, indicating
-
effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
March 29, 2012 - For example, family history of heart disease
is a measured variable indicating someone’s risk for
cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
April 01, 2010 - REQUEST FOR TASK ORDER
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ's Effective Health Care Program. It is a collaborative network of research centers that
support the rapid development of new scientific information and analytic tools. The DEcIDE
network…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/healthcare-infections_disposition-comments.pdf
August 10, 2015 - However, in the
background section there is no overviewing content
indicating that the physical action … implies that determining a safe
threshold of contamination is feasible
We have added text to page 9 indicating … We
have added text to the Background
indicating the threat of contamination on both
porous and nonporous … Regarding the incorrect citing of reference
47, we have revised the text indicating that
the study
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_research-protocol.pdf
September 22, 2014 - antibiotics-respiratory-infection-protocol-140922
Evidence-based Practice Center Systematic Review Protocol
Project Title: Interventions to Improve Appropriate Antibiotic Use for Acut…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
September 15, 2008 - Updating Current Effectiveness Reviews
Assessment of the Need to Update Comparative Effectiveness
Reviews:
Report of an Initial Rapid Program Assessment (2005-2009)
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
September 08, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: September 8, 2011
Evidence-based Practice Center Systematic Review Protocol
Project Title: Procalcitonin for Diagnosis and Management of Sepsis
Amendment Date(s) if applicable:
(Amendm…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper.pdf
September 01, 2015 - definition used, C-indices ranged between 0.56 (95% CI, 0.47 to 0.66) and 0.58 (95% CI,
0.50 to 0.67) indicating … comparisons were
statistically significantly different based on the Hosmer-Lemeshow test (Table 5), indicating
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
August 01, 2014 - FRN 29: Future Research Needs on Procalcitonin-Guided Antibiotic Therapy
Future Research Needs Paper
Number 29
Future Research Needs
on Procalcitonin-
Guided Antibiotic
Therapy
Future Research Needs Paper
Number 29
Future Research Needs on Procalcitonin-Guided
Antibiotic Therapy
Identification of Fu…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
August 01, 2014 - Electrocardiograms (ECGs) are frequently
abnormal in CKD patients (indicating left ventricular
hypertrophy … classified the strength of evidence pertaining to the
KQs into four basic grades: (1) “high” grade (indicating … research is very unlikely to change our
confidence in the estimate of the effect), (2) “moderate”
grade (indicating … change our confidence in the estimate of the effect and
may change the estimate), (3) “low” grade (indicating … Generally, the direction of association
was similar (indicating increased risk for elevated troponin
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
November 27, 2017 - transported are much
more likely to have a GCS
score of 14 or 15 than
those who are transported,
indicating … transported patients are
much more likely to have a
GCS score of 14 or 15
than those transported,
indicating … This poster highlighted ‘real
world’ survey data indicating that:
• Narcan® Nasal Spray was successful … Further indicating the report is "based on
research conducted by an Evidence-based
Practice center … Therefore, while formulary
administrations are addressed, there is no
significant data indicating "
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
September 01, 2012 - PCD (MM, nonsecretory MM,
or AL amyloidosis), is the SFLC assay better than traditional tests in indicating … (MM, nonsecretory
MM, or AL
amyloidosis), is the
SFLC assay better
than traditional
tests in indicating … PCD (MM, nonsecretory MM,
or AL amyloidosis), is the SFLC assay better than traditional tests in indicating … (MM, nonsecretory
MM, or AL
amyloidosis), is
the SFLC assay
better than
traditional tests in
indicating … of PCD (MM, nonsecretory MM, or AL amyloidosis), is the
SFLC assay better than traditional tests in indicating
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
December 01, 2012 - Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer
Gene Expression Profiling
for Predicting Outcomes
in Stage II Colon Cancer
Technical Brief
Number 13
Technical Brief
Number 13
Gene Expression Profiling for Predicting Outcomes in
Stage II Colon Cancer
…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-evidence-summary.pdf
March 01, 2021 - Evidence Summary: Comparative Effectiveness Review No. 238: Cervical Ripening
Comparative Effectiveness Review
Number 238
Cervical Ripening in the Outpatient
Setting
Evidence Summary
Main Points
• The highest strength of evidence for outcomes of outpatient cervical ripening
found in this report was low, with …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
January 01, 2011 - As a
result, ZPP levels increase, indicating iron deficiency.13
• Soluble transferrin receptor (sTfR